M, A., A, A., NT, I., AS, P., R, v. E., T, F., & T, T. (2026). Anchored Matching-Adjusted Indirect Comparison of the Long-Term Maintenance of Efficacy of Tralokinumab and Lebrikizumab in Patients with Moderate-to-Severe Atopic Dermatitis. Dermatology and therapy, 16(1), 277. https://doi.org/10.1007/s13555-025-01563-3
Chicago Style (17th ed.) CitationM, Augustin, Armstrong A, Issa NT, Petersen AS, von Eyben R, Festini T, and Torres T. "Anchored Matching-Adjusted Indirect Comparison of the Long-Term Maintenance of Efficacy of Tralokinumab and Lebrikizumab in Patients with Moderate-to-Severe Atopic Dermatitis." Dermatology and Therapy 16, no. 1 (2026): 277. https://doi.org/10.1007/s13555-025-01563-3.
MLA (9th ed.) CitationM, Augustin, et al. "Anchored Matching-Adjusted Indirect Comparison of the Long-Term Maintenance of Efficacy of Tralokinumab and Lebrikizumab in Patients with Moderate-to-Severe Atopic Dermatitis." Dermatology and Therapy, vol. 16, no. 1, 2026, p. 277, https://doi.org/10.1007/s13555-025-01563-3.